NCT07328984 How Long Should we Give Steroids for Patients With Severe PCP Status NOT_YET_RECRUITING Phase PHASE4
NCT02406651 Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD Status COMPLETED Phase PHASE1/PHASE2
NCT01079988 Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence Status COMPLETED Phase PHASE4